Stock Spotlight Archives - Page 181 of 378

ThursdayMay 27, 2021 11:55 am

QualityStocksNewsBreaks – Healthy Extracts Inc.’s (HYEX) Leading Products Backed by Research, Clinical Studies

Healthy Extracts (OTCQB: HYEX), through its two subsidiaries, BergaMet NA(TM) and Ultimate Brain Nutrients(TM) (“UBN”), is focused on the research, development and sale of natural plant-based formulations offering benefits for cardiovascular and neuro health. The targeting of these two high-growth categories reflects Healthy Extracts’ commitment to strengthening its position in the multibillion nutraceuticals market. “Research and clinical studies show positive results for two leading products of the company, BergaMet North America’s HERHEART(TM) and Ultimate Brain Nutrients’ Fuel4Thought(TM) Brain Booster. Clinical studies show positive results in brain activation, sports vision, cognitive function, clarity, energy, and ketone benefits (https://ibn.fm/WGKZN),” reads a recent…

ThursdayMay 27, 2021 11:39 am

QualityStocksNewsBreaks – Hero Technologies Inc. (HENC) Strengthens Balance Sheet with Veteran Hemp

Hero Technologies (OTC: HENC) recently received an independent third-party valuation and purchase price allocation for the acquisition of the assets of Veteran Hemp Co. “In November 2020, Hero Technologies entered into a purchase agreement to acquire all the assets of Veteran Hemp Co. from Patriot Shield National LLC,” reads a recent article. Veteran Hemp Co., which offers hemp that is tested, tasted and veteran approved, is committed to providing quality, consistent, delicious product, and it accomplishes this by working with the best farmers in the country, delivering the best genetics, helping at every point along the way, and packaging only…

WednesdayMay 26, 2021 1:51 pm

QualityStocksNewsBreaks – Why BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Is ‘One to Watch’

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), based in British Columbia, Canada, and founded in 2017, is a diversified health and wellness beverage and natural products company. BevCanna is focused on developing and manufacturing a range of plant-based and cannabinoid beverages and supplements. The company offers end-to-end turnkey beverage manufacturing solutions. A recent article discussing this reads, “BevCanna is a manufacturer of traditional and cannabis-infused beverage brands serving a growing roster of white-label clients in addition to operating a portfolio of in-house and partner brands. The company offers a full-service white-label beverage manufacturing solution.” To view the full article,…

WednesdayMay 26, 2021 1:24 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Study Promising Candidate in Phase 2 GBM Trial

CNS Pharmaceuticals (NASDAQ: CNSP) is on track to begin a potentially pivotal Phase 2 trial during the second quarter of 2021. This trial of CNSP’s lead drug candidate, Berubicin, in the treatment of glioblastoma multiforme (“GBM”) is currently planned to include up to 243 subjects, randomized 2:1 (162 Berubicin/81 Lomustine) with an interim analysis when 50% of the subjects reach six months in the study. “As the first anthracycline to cross the blood-brain barrier, Berubicin was specifically designed to attack a variety of primary brain cancers and cancers metastatic to the brain,” reads a recent article on the novel candidate.…

WednesdayMay 26, 2021 1:11 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Adds Insight, Strengthens Positioning Through Strategic Board Appointment

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, recently expanded its board of directors with the appointment of Dr. Christina Jenkins. Dr. Jenkins holds capital markets expertise coupled with health care experience through roles that span clinical medicine, venture capital, health plans, and health care systems. Her unique skillset, multivariate perspective and extensive experience have enabled her to create growth-optimizing strategies for health care providers while improving patients’ outcomes. A recent article discussing the appointment quoted POAI CEO J. Melville Engle as saying, “We are very fortunate to have…

WednesdayMay 26, 2021 1:00 pm

QualityStocksNewsBreaks – Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Breakthrough Cancer Visualization Technology Holds Significant Potential

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, is looking to change how cystoscopies for bladder cancer are performed with the goal of potentially lowering recurrence rates and ultimately helping improve patients’ lives and long-term outlook. “The company’s i/Blue Imaging System(TM) is a breakthrough cancer visualization technology currently in the manufacturing stage with Lighthouse Imaging, an FDA registered and ISO 13485:2016 certified contract manufacturer located in Maine. The project is on track for completion in 2022,” reads a recent article on the innovative solution. “Imagin Medical’s i/Blue Imaging System has the potential to revolutionize current cystoscopies by showing…

TuesdayMay 25, 2021 2:47 pm

QualityStocksNewsBreaks – Nextech AR Solutions Corp. (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29) President Looks to Transformative Potential of AR

Nextech (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29), a provider of virtual and augmented reality (“AR”) experience technologies and services for e-commerce, education, advertising, conferences and events, is poised to continue growing through the coming years thanks to the disruptive capabilities of AR. A 2017 Harvard Business Review article projected that AR, which at that time was in its infancy, would soon become mainstream and transform various industries. In a podcast interview with Oren Klaff, Nextech president Paul Duffy also gave a positive outlook for the AR market. A recent article quoted him as saying, “The whole concept of…

TuesdayMay 25, 2021 2:36 pm

QualityStocksNewsBreaks – FingerMotion Inc. (FNGR) Strengthening Partnerships with China Telecom Giants

FingerMotion (OTCQX: FNGR), an evolving technology company, is one of only a handful of companies in China with access to wholesale rechargeable minutes from China’s largest mobile phone providers — China Mobile, China Telecom and China Unicom — that can be resold to consumers. By constantly evolving its core competencies in mobile payment and recharge platform solutions in mainland China, FNGR has positioned itself to capitalize on the growth of the telecom market and its relationships with telecommunication companies. According to a recent article, FNGR “is currently working to strengthen the existing and strategic partnerships it has with Chinese telecommunication…

TuesdayMay 25, 2021 1:52 pm

QualityStocksNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Able to Fully Fund Physical Uranium Initiative

Uranium Energy (NYSE American: UEC), a Texas-based uranium mining and exploration company, was the subject of a recent research report by H.C. Wainwright & Co. (“Wainwright”). The analysts reiterated a buy rating for UEC’s stock, which, as they project, would reach a price target of $5. According to an article reporting the matter, the price projection and the buy rating are “based on a discounted cash flow (‘DCF’) model of future operations and in situ asset values.” Wainwright used a revised discount rate of 7.5%, as well as the value of assets, including Reno Creek ($75.0M), Alto Parana ($41.5M), Paraguay…

TuesdayMay 25, 2021 1:36 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Expands Team to Add Deep Clinical, Commercial and Regulatory Expertise

Cybin (NEO: CYBN) (OTCQB: CLXPF), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, recently appointed Alexander Belser as its chief clinical officer and Aaron Bartlone to serve as chief operating officer. Belser and Bartlone bring a wealth of experience and will provide the company with added insight and expertise in the expansion of its development and clinical operations in the U.S. and Europe. A recent article quoted Cybin CEO Doug Drysdale as saying, “These appointments will serve to strengthen our development and clinical operations globally and solidify Cybin’s position within the industry. Alex and Aaron…

Site Search

Company Search

Category: Stock Spotlight